Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
19 mars 2024 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
12 mars 2024 16h50 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 mars 2024 18h40 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
01 mars 2024 06h30 HE
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2023 total revenue of $6.3 million, representing 45% growth compared to fourth quarter 2022 Reports 2023 revenue of $22.5 million, representing 31% growth compared to 2022 ...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
27 févr. 2024 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
20 févr. 2024 16h36 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
10 janv. 2024 07h22 HE
|
Rapid Micro Biosystems, Inc.
The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company’s fully automated Growth Direct system and delivers time to organism...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
10 janv. 2024 07h20 HE
|
Rapid Micro Biosystems, Inc.
Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year Fourth quarter 2023 total revenue expected to be...
Samsung Biologics เลือกแพลตฟอร์ม Growth Direct® ของ Rapid Micro Biosystems เพื่อทำการทดสอบการควบคุมคุณภาพทางจุลชีววิทยาที่สำคัญโดยอัตโนมัติ
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
โลเวลล์ แมสซาชูเซตส์ , Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“บริษัท”)...
Samsung Biologics 選擇 Rapid Micro Biosystems 的 Growth Direct® 平台以自動化關鍵微生物品質控制測試
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
羅威爾，麻薩諸塞州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID)（以下簡稱「公司」）是一間創新生命科學技術公司，提供關鍵任務自動化解決方案，以促進醫療保健產品的高效生產和快速、安全發布。該公司今日宣布 Samsung Biologics (KRX: 207940.KS) 選擇了...